Journal article
Drug targeting of one or more aminoacyl-tRNA synthetase in the malaria parasite Plasmodium falciparum
- Abstract:
- Malaria remains a major infectious disease and, despite incidence reduction, it threatens resurgence in drug-resistant forms. Antimalarial drugs remain the mainstay of therapeutic options and hence there is a constant need to identify and validate new druggable targets. Plasmodium falciparum aminoacyl-tRNA synthetases (Pf-aaRSs) drive protein translation and are potent targets for development of next-generation antimalarials. Here, we detail advances made in structural-biology-based investigations in Pf-aaRSs and discuss their distribution of druggable pockets. This review establishes a platform for systematic experimental dissection of malarial parasite aaRSs as a new focus for sustained drug development efforts against malaria.
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Authors
- Publisher:
- Elsevier
- Journal:
- Drug Discovery Today More from this journal
- Volume:
- 23
- Issue:
- 6
- Pages:
- 1233-1240
- Publication date:
- 2018-02-08
- DOI:
- EISSN:
-
1878-5832
- ISSN:
-
1359-6446
- Pmid:
-
29408369
- Language:
-
English
- Pubs id:
-
pubs:823474
- UUID:
-
uuid:1853ec10-9669-4ba1-b224-d914ed01f71f
- Local pid:
-
pubs:823474
- Source identifiers:
-
823474
- Deposit date:
-
2018-05-31
Terms of use
- Copyright holder:
- Elsevier Ltd
- Copyright date:
- 2018
If you are the owner of this record, you can report an update to it here: Report update to this record